Advancing AI in Life Sciences

Anthropic Buys Coefficient Bio for $400 Million

The acquisition aims to accelerate drug research by integrating biology-native AI into laboratory workflows.

By Avantgarde News Desk··1 min read
A futuristic laboratory with digital displays of genetic data and artificial intelligence interfaces.

A futuristic laboratory with digital displays of genetic data and artificial intelligence interfaces.

Photo: Avantgarde News

Anthropic acquired biotech startup Coefficient Bio for $400 million [1][2]. The startup develops AI models to automate laboratory workflows and drug research [1][3]. This move marks a significant expansion for Anthropic into the life sciences sector [2]. The Coefficient Bio team will join Anthropic’s healthcare and life sciences group [1]. They plan to build biology-native AI systems to speed up discovery processes [1][3]. The deal reflects growing interest in applying large language models to complex biological data [2].

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Minimal

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers advancing ai in life sciences and editorial analysis for Avantgarde News.